| Dr Seif Elbualy, MD | |
|
800 Meadows Rd, Boca Raton, FL 33486-2304 | |
| (561) 955-4600 | |
| (619) 555-1285 |
| Full Name | Dr Seif Elbualy |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 32 Years |
| Location | 800 Meadows Rd, Boca Raton, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881644979 | NPI | - | NPPES |
| 2174908 | Medicaid | LA | |
| 378319700 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | ME0067941 (Florida) | Secondary |
| 207LP2900X | Anesthesiology - Pain Medicine | ME0067941 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Boca Raton Regional Hospital | Boca raton, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bocacare Inc | 3870633753 | 157 |
News Archive
Nutrastar International Inc., a leading producer and supplier of premium branded Traditional Chinese Medicine consumer products, today announced record financial results for the three and six months ended June 30, 2011.
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that the US Food and Drug Administration (FDA) has approved its orphan drug ERWINAZE (asparaginase Erwinia chrysanthemi) for the treatment of acute lymphoblastic leukemia (ALL) in patients with hypersensitivity to E. coli-derived asparaginase.
Preliminary findings in ferrets suggest that the novel 2009 H1N1 influenza virus may outcompete human seasonal influenza viruses, researchers say. Tests in animals showed that levels of the 2009 H1N1 virus rose more quickly than levels of the seasonal virus strains, and the new virus caused more severe disease. In line with previous findings by other research groups, the University of Maryland researchers also observed that the novel H1N1 virus was transmitted more easily from infected to uninfected ferrets than either of the two seasonal influenza viruses.
NeuroMark, a Boulder, Colorado company, announced today the immediate availability of a genetic test to identify people at risk of suicidal ideation - thoughts of committing suicide - when prescribed an antidepressant drug.
Metabolon, Inc., the leader in global metabolism, biomarker discovery and analysis, announces the publication of "Ethylene Glycol Monomethyl Ether-Induced Toxicity is Mediated through the Inhibition of Flavoprotein Dehydrogenase Enzyme Family", in the journal Toxicological Sciences on July 8, 2010. The paper was co-authored by Dr. Makoto Takei and colleagues at Daiichi-Sankyo in collaboration with Metabolon scientists.
› Verified 2 days ago
| Entity Name | Sheridan Healthcorp Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629781711 PECOS PAC ID: 3173429693 Enrollment ID: O20031208000355 |
News Archive
Nutrastar International Inc., a leading producer and supplier of premium branded Traditional Chinese Medicine consumer products, today announced record financial results for the three and six months ended June 30, 2011.
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that the US Food and Drug Administration (FDA) has approved its orphan drug ERWINAZE (asparaginase Erwinia chrysanthemi) for the treatment of acute lymphoblastic leukemia (ALL) in patients with hypersensitivity to E. coli-derived asparaginase.
Preliminary findings in ferrets suggest that the novel 2009 H1N1 influenza virus may outcompete human seasonal influenza viruses, researchers say. Tests in animals showed that levels of the 2009 H1N1 virus rose more quickly than levels of the seasonal virus strains, and the new virus caused more severe disease. In line with previous findings by other research groups, the University of Maryland researchers also observed that the novel H1N1 virus was transmitted more easily from infected to uninfected ferrets than either of the two seasonal influenza viruses.
NeuroMark, a Boulder, Colorado company, announced today the immediate availability of a genetic test to identify people at risk of suicidal ideation - thoughts of committing suicide - when prescribed an antidepressant drug.
Metabolon, Inc., the leader in global metabolism, biomarker discovery and analysis, announces the publication of "Ethylene Glycol Monomethyl Ether-Induced Toxicity is Mediated through the Inhibition of Flavoprotein Dehydrogenase Enzyme Family", in the journal Toxicological Sciences on July 8, 2010. The paper was co-authored by Dr. Makoto Takei and colleagues at Daiichi-Sankyo in collaboration with Metabolon scientists.
› Verified 2 days ago
| Entity Name | Bocacare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104058940 PECOS PAC ID: 3870633753 Enrollment ID: O20091228000461 |
News Archive
Nutrastar International Inc., a leading producer and supplier of premium branded Traditional Chinese Medicine consumer products, today announced record financial results for the three and six months ended June 30, 2011.
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that the US Food and Drug Administration (FDA) has approved its orphan drug ERWINAZE (asparaginase Erwinia chrysanthemi) for the treatment of acute lymphoblastic leukemia (ALL) in patients with hypersensitivity to E. coli-derived asparaginase.
Preliminary findings in ferrets suggest that the novel 2009 H1N1 influenza virus may outcompete human seasonal influenza viruses, researchers say. Tests in animals showed that levels of the 2009 H1N1 virus rose more quickly than levels of the seasonal virus strains, and the new virus caused more severe disease. In line with previous findings by other research groups, the University of Maryland researchers also observed that the novel H1N1 virus was transmitted more easily from infected to uninfected ferrets than either of the two seasonal influenza viruses.
NeuroMark, a Boulder, Colorado company, announced today the immediate availability of a genetic test to identify people at risk of suicidal ideation - thoughts of committing suicide - when prescribed an antidepressant drug.
Metabolon, Inc., the leader in global metabolism, biomarker discovery and analysis, announces the publication of "Ethylene Glycol Monomethyl Ether-Induced Toxicity is Mediated through the Inhibition of Flavoprotein Dehydrogenase Enzyme Family", in the journal Toxicological Sciences on July 8, 2010. The paper was co-authored by Dr. Makoto Takei and colleagues at Daiichi-Sankyo in collaboration with Metabolon scientists.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Seif Elbualy, MD 800 Meadows Rd, Boca Raton, FL 33486-2304 Ph: (561) 955-4600 | Dr Seif Elbualy, MD 800 Meadows Rd, Boca Raton, FL 33486-2304 Ph: (561) 955-4600 |
News Archive
Nutrastar International Inc., a leading producer and supplier of premium branded Traditional Chinese Medicine consumer products, today announced record financial results for the three and six months ended June 30, 2011.
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that the US Food and Drug Administration (FDA) has approved its orphan drug ERWINAZE (asparaginase Erwinia chrysanthemi) for the treatment of acute lymphoblastic leukemia (ALL) in patients with hypersensitivity to E. coli-derived asparaginase.
Preliminary findings in ferrets suggest that the novel 2009 H1N1 influenza virus may outcompete human seasonal influenza viruses, researchers say. Tests in animals showed that levels of the 2009 H1N1 virus rose more quickly than levels of the seasonal virus strains, and the new virus caused more severe disease. In line with previous findings by other research groups, the University of Maryland researchers also observed that the novel H1N1 virus was transmitted more easily from infected to uninfected ferrets than either of the two seasonal influenza viruses.
NeuroMark, a Boulder, Colorado company, announced today the immediate availability of a genetic test to identify people at risk of suicidal ideation - thoughts of committing suicide - when prescribed an antidepressant drug.
Metabolon, Inc., the leader in global metabolism, biomarker discovery and analysis, announces the publication of "Ethylene Glycol Monomethyl Ether-Induced Toxicity is Mediated through the Inhibition of Flavoprotein Dehydrogenase Enzyme Family", in the journal Toxicological Sciences on July 8, 2010. The paper was co-authored by Dr. Makoto Takei and colleagues at Daiichi-Sankyo in collaboration with Metabolon scientists.
› Verified 2 days ago
Anthony Riso, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 771 Ne 33rd St, Boca Raton, FL 33431 Phone: 561-247-1020 Fax: 954-510-2060 | |
Dr. Juan P Giraldo, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 660 Glades Rd, Suite 460, Boca Raton, FL 33431 Phone: 561-391-5515 Fax: 561-347-7470 | |
Dr. Erik A Cooper, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 7926 Tennyson Ct, Boca Raton, FL 33433 Phone: 412-728-4256 | |
Dr. Kenneth Lawrence Ross, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 785 Ne 33rd St, Boca Raton, FL 33431 Phone: 561-750-1130 Fax: 561-750-1130 | |
George R Luck, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 800 Meadows Rd, Boca Raton, FL 33486 Phone: 561-395-7100 | |
Azra Khan, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 7100 W Camino Real, Suite 301, Boca Raton, FL 33433 Phone: 772-924-2527 | |
Dr. David Lee Dresner, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 22503 Esplanada Cir W, Boca Raton, FL 33433 Phone: 561-562-7755 |